Publication | Closed Access

Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells

Tumor BiologyGastrointestinal Peptide HormoneAngiogenesisImmunologyEndothelial DysfunctionPathologyVascular BiologyVascular Endothelial Growth FactorMedicineCancer GrowthVasoactive Intestinal PeptideTumor MicroenvironmentCancer ResearchExtracellular Matrix